News on FDA action in September 2002 related to the dual 5HT/noradrenaline reuptake inhibitor (also known as Cymbalta) for the treatment of depression. www.ims-global.com
Medicine-News article on findings of studies comparing this medication with fluoxetine (Prozac) and placebo over a period of eight weeks. May 2001. www.medicine-news.com